Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Imazio

Showing results (401-410 of 483) with videos related to

Pageof 49
Sort By:
Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs]Maurizio Giuseppe Abrignani, Angelo Zullo, Domenico Gabrielli, et al.
ESC Heart Failure|November 27, 2025
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial DiseasesMarco Merlo, Giulia Bassetto, Antonio Cannatà, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 11, 2024
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseasesMassimo Imazio, Valentino Collini, Alberto Aimo, et al.
JAMA|November 9, 2016
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical TrialAntonio Brucato, Massimo Imazio, Marco Gattorno, et al.
Trends in Cardiovascular Medicine|January 14, 2026
Myocarditis and Pericarditis in Focus: A Critical Appraisal of the 2025 ESC vs ACC Position Statements from the Italian Society of Cardiology Working Group on Cardiomyopathies and Pericardial DiseasesMassimo Imazio, Valentino Collini, Marco Merlo, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 16, 2024
ANMCO POSITION PAPER: The role of cardiology in the management of the health needs in the post-Covid-19 eraAdriano Murrone, Furio Colivicchi, Loris Roncon, et al.
Journal of the American Heart Association|March 12, 2024
Sustained Pericarditis Recurrence Risk Reduction With Long-Term RilonaceptMassimo Imazio, Allan L Klein, Antonio Brucato, et al.
Journal of the American Heart Association|October 17, 2022
Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODYAntonio Brucato, Michelle Z Lim-Watson, Allan Klein, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2021
[ANMCO Position paper: Reorganization of cardiology in the era of the COVID-19 pandemic]Pasquale Caldarola, Adriano Murrone, Loris Roncon, et al.
Pageof 49

Showing results (401-410 of 483) with videos related to

Sort By:
Pageof 49
Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs]Maurizio Giuseppe Abrignani, Angelo Zullo, Domenico Gabrielli, et al.
ESC Heart Failure|November 27, 2025
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial DiseasesMarco Merlo, Giulia Bassetto, Antonio Cannatà, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 11, 2024
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseasesMassimo Imazio, Valentino Collini, Alberto Aimo, et al.
JAMA|November 9, 2016
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical TrialAntonio Brucato, Massimo Imazio, Marco Gattorno, et al.
Trends in Cardiovascular Medicine|January 14, 2026
Myocarditis and Pericarditis in Focus: A Critical Appraisal of the 2025 ESC vs ACC Position Statements from the Italian Society of Cardiology Working Group on Cardiomyopathies and Pericardial DiseasesMassimo Imazio, Valentino Collini, Marco Merlo, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 16, 2024
ANMCO POSITION PAPER: The role of cardiology in the management of the health needs in the post-Covid-19 eraAdriano Murrone, Furio Colivicchi, Loris Roncon, et al.
Journal of the American Heart Association|March 12, 2024
Sustained Pericarditis Recurrence Risk Reduction With Long-Term RilonaceptMassimo Imazio, Allan L Klein, Antonio Brucato, et al.
Journal of the American Heart Association|October 17, 2022
Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODYAntonio Brucato, Michelle Z Lim-Watson, Allan Klein, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2021
[ANMCO Position paper: Reorganization of cardiology in the era of the COVID-19 pandemic]Pasquale Caldarola, Adriano Murrone, Loris Roncon, et al.
Pageof 49